| Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics L Pastorelli, C De Salvo, JR Mercado, M Vecchi, TT Pizarro Frontiers in immunology 4, 280, 2013 | 501 | 2013 |
| IL-33 activates tumor stroma to promote intestinal polyposis RL Maywald, SK Doerner, L Pastorelli, C De Salvo, SM Benton, ... Proceedings of the National Academy of Sciences 112 (19), E2487-E2496, 2015 | 177 | 2015 |
| A signalling cascade of IL-33 to IL-13 regulates metaplasia in the mouse stomach CP Petersen, AR Meyer, C De Salvo, E Choi, C Schlegel, A Petersen, ... Gut 67 (5), 805-817, 2018 | 111 | 2018 |
| GSDMB is increased in IBD and regulates epithelial restitution/repair independent of pyroptosis N Rana, G Privitera, HC Kondolf, K Bulek, S Lechuga, C De Salvo, ... Cell 185 (2), 283-298. e17, 2022 | 110 | 2022 |
| IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair LR Lopetuso, C De Salvo, L Pastorelli, N Rana, HN Senkfor, V Petito, ... Proceedings of the National Academy of Sciences 115 (40), E9362-E9370, 2018 | 99 | 2018 |
| The role of IL‐33 in gut mucosal inflammation L Pastorelli, C De Salvo, M Vecchi, TT Pizarro Mediators of inflammation 2013 (1), 608187, 2013 | 83 | 2013 |
| IL-33 drives eosinophil infiltration and pathogenic type 2 helper T-cell immune responses leading to chronic experimental ileitis C De Salvo, XM Wang, L Pastorelli, B Mattioli, S Omenetti, KA Buela, ... The American Journal of Pathology 186 (4), 885-898, 2016 | 67 | 2016 |
| Novel cytokine signaling pathways in inflammatory bowel disease: insight into the dichotomous functions of IL-33 during chronic intestinal inflammation L Pastorelli, C De Salvo, MA Cominelli, M Vecchi, TT Pizarro Therapeutic advances in gastroenterology 4 (5), 311-323, 2011 | 62 | 2011 |
| Central role of IL-17/Th17 immune responses and the gut microbiota in the pathogenesis of intestinal fibrosis S Ray, C De Salvo, TT Pizarro Current opinion in gastroenterology 30 (6), 531-538, 2014 | 54 | 2014 |
| Interleukin 33 triggers early eosinophil-dependent events leading to metaplasia in a chronic model of gastritis-prone mice C De Salvo, L Pastorelli, CP Petersen, LF Buttò, KA Buela, S Omenetti, ... Gastroenterology 160 (1), 302-316. e7, 2021 | 44 | 2021 |
| Estrogen receptor α loss-of-function protects female mice from DSS-induced experimental colitis WA Goodman, HL Havran, HA Quereshy, S Kuang, C De Salvo, ... Cellular and Molecular Gastroenterology and Hepatology 5 (4), 630-633. e1, 2018 | 42 | 2018 |
| KLF6 contributes to myeloid cell plasticity in the pathogenesis of intestinal inflammation WA Goodman, S Omenetti, D Date, L Di Martino, C De Salvo, GD Kim, ... Mucosal immunology 9 (5), 1250-1262, 2016 | 42 | 2016 |
| NOD2 drives early IL-33–dependent expansion of group 2 innate lymphoid cells during Crohn’s disease–like ileitis C De Salvo, KA Buela, B Creyns, D Corridoni, N Rana, HL Wargo, ... The Journal of clinical investigation 131 (5), 2021 | 30 | 2021 |
| Candida tropicalis infection modulates the gut microbiome and confers enhanced susceptibility to colitis in mice L Di Martino, C De Salvo, KA Buela, C Hager, M Ghannoum, A Osme, ... Cellular and Molecular Gastroenterology and Hepatology 13 (3), 901-923, 2022 | 19 | 2022 |
| Cytokine-mediated regulation of innate lymphoid cell plasticity in gut mucosal immunity C De Salvo, KA Buela, TT Pizarro Frontiers in immunology 11, 585319, 2020 | 19 | 2020 |
| Mechanisms and models for intestinal fibrosis in IBD C De Salvo, S Ray, TT Pizarro Digestive Diseases 32 (Suppl. 1), 26-34, 2014 | 19 | 2014 |
| Chronic stress induces colonic tertiary lymphoid organ formation and protection against secondary injury through IL-23/IL-22 signaling A Gomez-Nguyen, N Gupta, H Sanaka, D Gruszka, A Pizarro, L DiMartino, ... Proceedings of the National Academy of Sciences 119 (40), e2208160119, 2022 | 7 | 2022 |
| Death-domain-receptor 3 deletion normalizes inflammatory gene expression and prevents ileitis in experimental Crohn’s disease LF Buttó, LG Jia, KO Arseneau, H Tamagawa, A Rodriguez-Palacios, Z Li, ... Inflammatory Bowel Diseases 25 (1), 14-26, 2019 | 7 | 2019 |
| IL-33-dependent induction of intestinal profibrotic gene expression and myofibroblast hypertrophy: potential role in inflammatory-associated gut fibrosis B Mattioli, L Pastorelli, CD Salvo, D Corridoni, RR Garg, G Poggioli, ... Gastroenterology 140 (5, supplement 1), S844-S845, 2011 | 6 | 2011 |
| Circulating OPG levels are reduced following infliximab treatment and correlate with CRP levels: is serum OPG a potential marker of IBD disease activity? E Galliera, L de Girolamo, G Dogliotti, C De Salvo, G Tosetti, L Pastorelli Inflammatory bowel diseases 17 (6), E59-E60, 2011 | 5 | 2011 |
Luca Pastorelliuniversità di milano, case western reserve university, university of virginia在 unimi.it 的电子邮件经过验证
